GDF15 overexpression
|
Oral Cancer
|
GDF15 overexpression
|
Oral Cancer
|
TPF Sensitive: C3 – Early Trials
|
TPF Sensitive: C3 – Early Trials
|
GDF15 overexpression
|
Oral Cancer
|
GDF15 overexpression
|
Oral Cancer
|
CI-1033 Sensitive: D – Preclinical
|
CI-1033 Sensitive: D – Preclinical
|